News

Provisor Marketing relaunching as an independent agency

BY Allison Cerra

DEER PARK, Ill. — Provisor Marketing announced it is becoming an independent agency after five years with the Emerson Group.

The company said it will continue its emphasis on small- to mid-size consumer packaged goods brands and will maintain focus on creating marketing strategy, planning and implementing for client brands in a competitive marketplace dominated by large brands.

For more information about Provisor Marketing, visit Provisormarketing.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Apple Cinnamon Chex goes gluten-free

BY Allison Cerra

MINNEAPOLIS — Chex has introduced a new apple cinnamon variety that also is gluten-free.

New Apple Cinnamon Chex will be available starting this month, the company said. "We’re thrilled to introduce a new choice for breakfast with show-stopping great taste," Chex marketing associate director Liz Abate Mascolo said. "New Apple Cinnamon Chex provides families, including those living a gluten-free lifestyle, with a wholesome and flavorful breakfast option they’ll love."

Chex gluten-free cereals are available on cereal shelves nationwide for an average retail price of $3.39 per box.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Obama signs PDUFA reauthorization

BY Alaric DeArment

WASHINGTON — President Barack Obama signed into law Monday what some called a "historic" reauthorization of the Prescription Drug User Fee Act.

Senate bill 3187, the Food and Drug Administration Safety and Innovation Act, passed in a 92-4 vote on June 26. Under the law, starting Oct. 1, the generic drug industry will pay $299 million a year in user fees over the next five years, which will help pay for more FDA staff and help clear a backlog of some 2,500 generic drug applications and more inspections of manufacturers’ production plants. The law also creates a user fee program for companies that make biosimilar drugs.

The new law, which is the fifth reauthorization of PDUFA since 1992, drew applause from a trade group representing generic drug manufacturers.

"Today’s enactment of the Food and Drug Administration Safety and Innovation Act is a remarkable achievement for patients, industry and the FDA," Generic Pharmaceutical Association president and CEO Ralph Neas said. "The historic user fee legislation — the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act — will provide FDA with additional resources and ensure all participants in the U.S. generic drug system, whether U.S.-based or foreign, comply with our country’s strict quality standards. Very importantly, the programs will make certain that all Americans receive timely access to safe, effective and affordable generic drugs."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?